Related Experiment Video
Updated: Oct 5, 2025

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
Constrictive pericarditis after SARS-CoV-2 vaccination: A case report
Yuki Nakanishi1, Sakiko Honda1, Michiyo Yamano1
1Department of Cardiology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan.
A rare case of constrictive pericarditis leading to right-sided heart failure occurred after mRNA COVID-19 vaccination. This highlights potential cardiac complications following SARS-CoV-2 vaccination.
Area of Science:
- Cardiology
- Immunology
- Vaccinology
Background:
- COVID-19 vaccination, particularly mRNA vaccines, has been linked to cardiovascular events.
- Constrictive pericarditis is a serious cardiac condition affecting heart function.
Observation:
- A 70-year-old woman developed symptoms of right-sided heart failure, including edema and dyspnea, one week after her second mRNA SARS-CoV-2 vaccine dose.
- Clinical signs such as elevated jugular venous pressure with a prominent y descent and Kussmaul's sign were noted.
- Serological tests confirmed vaccine-induced antibodies without evidence of active COVID-19 infection.
Findings:
- Echocardiography revealed pericardial thickening and interventricular septal bounce.
- CT scans corroborated the presence of pericardial thickening.
- Cardiac catheterization confirmed constrictive pericarditis, leading to right-sided heart failure.
Implications:
- This case suggests a potential association between mRNA SARS-CoV-2 vaccination and the development of constrictive pericarditis.
- Further research is warranted to understand the mechanisms and incidence of vaccine-associated pericarditis.
- Clinicians should remain vigilant for cardiac complications in patients presenting with symptoms post-vaccination.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020